Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
|Articles|December 9, 2021
Florida Cancer Specialists & Research Institute Announces Senior Leadership Promotions & Appointments
Promotions and additions to the senior leadership team of Florida Cancer Specialists & Research Institute.
Advertisement
Fort Myers, Florida —
- Chris Chadwick has joined FCS as vice president of Service Delivery & Infrastructure
- Inga Gonzalez has been promoted to senior vice president of Practice Operations
- John Mills has been promoted to vice president of Pharmacy Services
- Marilyn Morales, EdS, MS, MBA, LBBP, CPT, has been promoted to senior vice president of Organizational Effectiveness and Learning
- Amy Pacey, MBA, SPHR, has joined FCS as senior vice president of People & Culture
- Jeffrey Rubin has been promoted to senior vice president of Practice Operations
FCS chief executive officer Nathan H. Walcker said, “These individuals bring a depth of diversity, talent, skill, and expertise that is valued and so vital to our ongoing success. Collectively, they will help to further enhance our national reputation for exceptional and compassionate patient.”
Advertisement
Related to this article
Merck has begun the phase 3 ENHANCE-3 trial testing whether ensifentrine added to standard of care prevents COPD exacerbations in high-risk adults.
Real-world study tracks JAK inhibitors in alopecia areata and atopic dermatitis, flagging menstrual alterations and weight gain as key safety signals.
Proposals to drop race questions from the 2030 census and end EEOC workforce reporting could leave gaps in national racial data.
SGLT2 inhibitors were linked to hemoglobin gains of about 1.0 to 1.6 g/dL in small MDS and MPN studies, but a review found no randomized trials to confirm.
Experts at GOLD 2026 say targeted case finding, AI, and guideline-based treatment can close COPD’s diagnostic gap and improve patient outcomes.
Phase 3 hepatitis delta data, MASH persistence and cost findings, and new PBC treatment targets led The Liver Meeting 2026 in Denver, Colorado.
A prospective Italian study of 492 postmenopausal women found ultrasound signs of deep endometriosis in 7.3%, often plaque-like and poorly vascularized.
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
3
The Liver Meeting 2026 Highlights Hepatitis Delta, PBC Targets, MASH Costs
4
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
5